Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection

Published:2003-11 Issue:11 Volume:15 Page:1203-1208
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Huo Teh-Ia,Wu Jaw-Ching,Lui Wing-Yu,Lee Pui-Ching,Huang Yi-Hsiang,Chau Gar-Yang,Tsay Shyh-Haw,Chang Full-Young,Lee Shou-Dong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Prognostic prediction and treatment strategy in hepatocellular carcinoma

2. Rising Incidence of Hepatocellular Carcinoma in the United States

3. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

4. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma;Hepatology Research;2023-05-30

2. Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes;Hepatology;2022-09-21

3. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study;European Journal of Surgical Oncology;2022-01

4. Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma;Computational and Structural Biotechnology Journal;2022

5. ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy;Journal of Gastrointestinal Oncology;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3